Novavax, Inc. (NVAX)
USD 5.43
(-19.56%)
USD 5.43
(-19.56%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 168.01 Million USD | -15.02% |
| 2022 | 197.7 Million USD | -38.88% |
| 2021 | 323.45 Million USD | -10.68% |
| 2020 | 362.11 Million USD | 12.95% |
| 2019 | 320.61 Million USD | 0.45% |
| 2018 | 319.18 Million USD | 0.45% |
| 2017 | 317.76 Million USD | 0.45% |
| 2016 | 316.33 Million USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 395 Thousand USD | -67.06% |
| 2013 | 1.19 Million USD | 21.11% |
| 2012 | 990 Thousand USD | 230.0% |
| 2011 | 300 Thousand USD | -6.25% |
| 2010 | 320 Thousand USD | -21.18% |
| 2009 | 406 Thousand USD | -15.42% |
| 2008 | 480 Thousand USD | -97.78% |
| 2007 | 21.62 Million USD | -3.69% |
| 2006 | 22.45 Million USD | -24.33% |
| 2005 | 29.67 Million USD | -17.49% |
| 2004 | 35.97 Million USD | -12.48% |
| 2003 | 41.1 Million USD | -0.23% |
| 2002 | 41.19 Million USD | 37.31% |
| 2001 | 30 Million USD | 50.0% |
| 2000 | 20 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 168.43 Million USD | 0.25% |
| 2024 Q2 | 168.84 Million USD | 0.25% |
| 2023 Q1 | 197.85 Million USD | 0.07% |
| 2023 Q4 | 168.01 Million USD | -23.9% |
| 2023 Q3 | 220.77 Million USD | 11.51% |
| 2023 Q2 | 197.99 Million USD | 0.07% |
| 2023 FY | 168.01 Million USD | -15.02% |
| 2022 FY | 197.7 Million USD | -38.88% |
| 2022 Q3 | 31.47 Million USD | -54.44% |
| 2022 Q4 | 197.7 Million USD | 528.15% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | 69.07 Million USD | 0.0% |
| 2021 Q4 | 323.45 Million USD | 0.11% |
| 2021 FY | 323.45 Million USD | -10.68% |
| 2021 Q1 | 339.08 Million USD | -6.36% |
| 2021 Q2 | 331.93 Million USD | -2.11% |
| 2021 Q3 | 323.1 Million USD | -2.66% |
| 2020 FY | 362.11 Million USD | 12.95% |
| 2020 Q3 | 384.77 Million USD | 19.75% |
| 2020 Q2 | 321.32 Million USD | 0.11% |
| 2020 Q1 | 320.96 Million USD | 0.11% |
| 2020 Q4 | 362.11 Million USD | -5.89% |
| 2019 Q1 | 319.54 Million USD | 0.11% |
| 2019 FY | 320.61 Million USD | 0.45% |
| 2019 Q4 | 320.61 Million USD | 0.11% |
| 2019 Q3 | 320.25 Million USD | 0.11% |
| 2019 Q2 | 319.89 Million USD | 0.11% |
| 2018 FY | 319.18 Million USD | 0.45% |
| 2018 Q1 | 318.11 Million USD | 0.11% |
| 2018 Q2 | 318.47 Million USD | 0.11% |
| 2018 Q3 | 318.83 Million USD | 0.11% |
| 2018 Q4 | 319.18 Million USD | 0.11% |
| 2017 Q1 | 316.69 Million USD | 0.11% |
| 2017 Q4 | 317.76 Million USD | 0.11% |
| 2017 Q3 | 317.4 Million USD | 0.11% |
| 2017 FY | 317.76 Million USD | 0.45% |
| 2017 Q2 | 317.05 Million USD | 0.11% |
| 2016 FY | 316.33 Million USD | 0.0% |
| 2016 Q4 | 316.33 Million USD | 0.11% |
| 2016 Q2 | 315.62 Million USD | 0.11% |
| 2016 Q1 | 315.27 Million USD | 0.0% |
| 2016 Q3 | 315.98 Million USD | 0.11% |
| 2015 FY | - USD | -100.0% |
| 2015 Q1 | 252 Thousand USD | -36.2% |
| 2015 Q4 | - USD | -100.0% |
| 2015 Q2 | 149 Thousand USD | -40.87% |
| 2015 Q3 | 45 Thousand USD | -69.8% |
| 2014 Q4 | 395 Thousand USD | -45.21% |
| 2014 FY | 395 Thousand USD | -67.06% |
| 2014 Q3 | 721 Thousand USD | -18.9% |
| 2014 Q2 | 889 Thousand USD | -15.49% |
| 2014 Q1 | 1.05 Million USD | -12.26% |
| 2013 Q3 | 1.87 Million USD | 0.86% |
| 2013 FY | 1.19 Million USD | 21.11% |
| 2013 Q4 | 1.19 Million USD | -36.05% |
| 2013 Q2 | 1.85 Million USD | 22.95% |
| 2013 Q1 | 1.51 Million USD | 52.73% |
| 2012 Q4 | 990 Thousand USD | -5.26% |
| 2012 Q1 | 400 Thousand USD | 33.33% |
| 2012 FY | 990 Thousand USD | 230.0% |
| 2012 Q2 | 400 Thousand USD | 0.0% |
| 2012 Q3 | 1.04 Million USD | 161.25% |
| 2011 FY | 300 Thousand USD | -6.25% |
| 2011 Q1 | 300 Thousand USD | -6.25% |
| 2011 Q2 | 300 Thousand USD | 0.0% |
| 2011 Q3 | 300 Thousand USD | 0.0% |
| 2011 Q4 | 300 Thousand USD | 0.0% |
| 2010 Q2 | 360 Thousand USD | -5.26% |
| 2010 Q3 | 340 Thousand USD | -5.56% |
| 2010 Q4 | 320 Thousand USD | -5.88% |
| 2010 Q1 | 380 Thousand USD | -6.4% |
| 2010 FY | 320 Thousand USD | -21.18% |
| 2009 Q4 | 406 Thousand USD | -6.24% |
| 2009 FY | 406 Thousand USD | -15.42% |
| 2009 Q1 | 468 Thousand USD | -2.5% |
| 2009 Q3 | 433 Thousand USD | -3.78% |
| 2009 Q2 | 450 Thousand USD | -3.85% |
| 2008 FY | 480 Thousand USD | -97.78% |
| 2008 Q2 | 21.79 Million USD | 0.38% |
| 2008 Q1 | 21.71 Million USD | 0.38% |
| 2008 Q3 | 200 Thousand USD | -99.08% |
| 2008 Q4 | 480 Thousand USD | 140.0% |
| 2007 Q4 | 21.62 Million USD | -0.86% |
| 2007 Q3 | 21.81 Million USD | 0.19% |
| 2007 Q2 | 21.77 Million USD | -2.77% |
| 2007 FY | 21.62 Million USD | -3.69% |
| 2007 Q1 | 22.39 Million USD | -0.28% |
| 2006 Q3 | 22.51 Million USD | -0.24% |
| 2006 Q4 | 22.45 Million USD | -0.25% |
| 2006 Q1 | 22.62 Million USD | -23.77% |
| 2006 FY | 22.45 Million USD | -24.33% |
| 2006 Q2 | 22.56 Million USD | -0.24% |
| 2005 FY | 29.67 Million USD | -17.49% |
| 2005 Q3 | 35.74 Million USD | -0.17% |
| 2005 Q4 | 29.67 Million USD | -16.98% |
| 2005 Q2 | 35.8 Million USD | -0.22% |
| 2005 Q1 | 35.88 Million USD | -0.23% |
| 2004 FY | 35.97 Million USD | -12.48% |
| 2004 Q2 | 40.99 Million USD | -0.13% |
| 2004 Q1 | 41.04 Million USD | -0.12% |
| 2004 Q3 | 36.04 Million USD | -12.07% |
| 2004 Q4 | 35.97 Million USD | -0.21% |
| 2003 Q3 | 41.29 Million USD | -0.12% |
| 2003 Q4 | 41.1 Million USD | -0.47% |
| 2003 Q1 | 41.43 Million USD | 0.59% |
| 2003 FY | 41.1 Million USD | -0.23% |
| 2003 Q2 | 41.34 Million USD | -0.21% |
| 2002 Q3 | 40 Million USD | 0.0% |
| 2002 Q4 | 41.19 Million USD | 2.98% |
| 2002 FY | 41.19 Million USD | 37.31% |
| 2002 Q1 | 30 Million USD | 0.0% |
| 2002 Q2 | 40 Million USD | 33.33% |
| 2001 FY | 30 Million USD | 50.0% |
| 2001 Q1 | 20 Million USD | 0.0% |
| 2001 Q3 | 30 Million USD | 50.0% |
| 2001 Q2 | 20 Million USD | 0.0% |
| 2001 Q4 | 30 Million USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | 20 Million USD | 0.0% |
| 2000 FY | 20 Million USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Keros Therapeutics, Inc. | 13.43 Million USD | -1150.212% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 92.829% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -2819.479% |
| AlloVir, Inc. | 16.64 Million USD | -909.226% |
| Precigen, Inc. | 5.89 Million USD | -2750.144% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -2604.265% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -438687.182% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -13831.675% |
| Acelyrin, Inc. | 1.19 Million USD | -13971.692% |
| AbCellera Biologics Inc. | 71.22 Million USD | -135.905% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -61.03% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | -22.35% |
| Dyadic International, Inc. | 88.87 Thousand USD | -188958.175% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -763609.091% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -273114.518% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 1.83 Million USD | -9036.27% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -386.214% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -1401.349% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -20069.988% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -135.991% |
| Alkermes plc | 287.73 Million USD | 41.606% |
| Aptorum Group Limited | 3.05 Million USD | -5393.412% |
| Ardelyx, Inc. | 51.54 Million USD | -225.947% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -60.615% |
| Bicycle Therapeutics plc | 40.08 Million USD | -319.202% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -67.017% |
| Chimerix, Inc. | 125 Thousand USD | -134312.8% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -5087.871% |
| CRISPR Therapeutics AG | 223 Million USD | 24.659% |
| Elevation Oncology, Inc. | 30.13 Million USD | -457.507% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Fortress Biotech, Inc. | 60.85 Million USD | -176.088% |
| Fortress Biotech, Inc. | 60.85 Million USD | -176.088% |
| NextCure, Inc. | 5.94 Million USD | -2724.273% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 118.85 Thousand USD | -141259.785% |
| Opthea Limited | 200.53 Million USD | 16.216% |
| PDS Biotechnology Corporation | 19.5 Million USD | -761.347% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -4320.31% |
| ImmuCell Corporation | 10.54 Million USD | -1494.005% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -14834.756% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -186327.589% |
| Incyte Corporation | 29.16 Million USD | -476.147% |
| Jaguar Health, Inc. | 30.99 Million USD | -442.11% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -629.711% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| ContextLogic Inc. | 6 Million USD | -2700.267% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -45.494% |
| MiMedx Group, Inc. | 48.09 Million USD | -249.313% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -735.942% |
| Seer, Inc. | 25.96 Million USD | -547.111% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -300.152% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -115773.103% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -169613.131% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -561.376% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 12.002% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -659.875% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -155.51% |
| Pharming Group N.V. | 166.1 Million USD | -1.15% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -21.483% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| PureTech Health plc | 18.25 Million USD | -820.636% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -219.07% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -401.316% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -36425.217% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -4357.84% |
| Senti Biosciences, Inc. | 33.53 Million USD | -400.972% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -3420.134% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -178.536% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -291.883% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -10601.656% |
| Windtree Therapeutics, Inc. | 15 Million USD | -1020.107% |
| ChromaDex Corporation | 2.57 Million USD | -6424.893% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -22853.005% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -548.51% |
| Precision BioSciences, Inc. | 7.72 Million USD | -2075.528% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -72.572% |
| Innoviva, Inc. | 446.23 Million USD | 62.348% |
| Summit Therapeutics Inc. | 103.29 Million USD | -62.664% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -251255.395% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 18.82% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -5170.263% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -16086.513% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -652.558% |
| Aptose Biosciences Inc. | 621 Thousand USD | -26955.717% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -16519.878% |
| Century Therapeutics, Inc. | 46.65 Million USD | -260.101% |
| Kura Oncology, Inc. | 9.33 Million USD | -1700.429% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -529.273% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -121650.725% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -1690.261% |
| Autolus Therapeutics plc | 47.91 Million USD | -250.662% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -3324.704% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -2380.673% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -28.59% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1972.992% |
| IGM Biosciences, Inc. | 34.67 Million USD | -384.587% |
| INmune Bio, Inc. | 397 Thousand USD | -42221.411% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 3.302% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4044.184% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -114236.266% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -237.571% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -207.891% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -267.706% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 64.506% |
| Verastem, Inc. | 40.08 Million USD | -319.139% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -3716.811% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1571.136% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -2460.829% |
| Histogen Inc. | 4.38 Million USD | -3732.482% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -18949.433% |
| Organovo Holdings, Inc. | 888 Thousand USD | -18820.721% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -460.053% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -3906.104% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -789.209% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -121.95% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -180360.56% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -548.535% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -62827.341% |
| Amarin Corporation plc | 8.73 Million USD | -1823.04% |
| Mesoblast Limited | 100.48 Million USD | -67.208% |
| Turnstone Biologics Corp. | 1.18 Million USD | -14030.866% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -114.5% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -154043.119% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -104.875% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 11.544% |
| Better Therapeutics, Inc. | 10.34 Million USD | -1523.657% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -626.556% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -80.598% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -12904.334% |
| Gritstone bio, Inc. | 40.14 Million USD | -318.533% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -9162.183% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -9.39% |
| Insmed Incorporated | 1.19 Billion USD | 85.921% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -2545.921% |
| OmniAb, Inc. | 22.07 Million USD | -661.114% |
| Alector, Inc. | 30.45 Million USD | -451.668% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -65.461% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -1987.933% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 60.615% |
| Aura Biosciences, Inc. | 16.87 Million USD | -895.945% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -195.314% |
| Immunic, Inc. | 639 Thousand USD | -26193.584% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -463.453% |
| Veracyte, Inc. | 7.52 Million USD | -2132.771% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 73.946% |
| FibroGen, Inc. | 89.69 Million USD | -87.315% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -3774.014% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -128290.76% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 96.711% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -453997.297% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -8385.657% |
| TG Therapeutics, Inc. | 100.11 Million USD | -67.818% |
| Galecto, Inc. | 66 Thousand USD | -254469.697% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -123441.176% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 89.707% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -2693.283% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3013.137% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -9162.183% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -683.401% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -359.625% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -32398.259% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -271.421% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -449.539% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -275.019% |
| Vaxxinity, Inc. | 13.26 Million USD | -1166.898% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 79.29% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -37315.628% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1811.662% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 93.784% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -53069.62% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -3668.865% |
| Ainos, Inc. | 5.92 Million USD | -2737.362% |
| Pluri Inc. | 29.05 Million USD | -478.309% |
| Prothena Corporation plc | 10.72 Million USD | -1467.167% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -746.386% |
| Celularity Inc. | 26.17 Million USD | -541.846% |
| Rallybio Corporation | 173 Thousand USD | -97019.075% |
| Cue Biopharma, Inc. | 4.2 Million USD | -3898.477% |
| MeiraGTx Holdings plc | 72.11 Million USD | -132.971% |
| Omeros Corporation | 329.7 Million USD | 49.041% |
| Humacyte, Inc. | 38.6 Million USD | -335.275% |
| Immunocore Holdings plc | 82.64 Million USD | -103.301% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -10316.367% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -4597.12% |
| Blueprint Medicines Corporation | 610.96 Million USD | 72.5% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -11423.731% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -76.508% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -245.115% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -84.834% |
| Pulmatrix, Inc. | 8.32 Million USD | -1917.725% |
| Elicio Therapeutics, Inc. | 6 Million USD | -2697.003% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -1197.922% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -73.665% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -35724.307% |
| Cytokinetics, Incorporated | 607.37 Million USD | 72.337% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -1832.996% |
| Nutriband Inc. | 79.82 Thousand USD | -210377.789% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -3647.012% |
| Vor Biopharma Inc. | 31.83 Million USD | -427.854% |
| Roivant Sciences Ltd. | 477.85 Million USD | 64.84% |
| Evogene Ltd. | 10.65 Million USD | -1477.171% |
| ProKidney Corp. | 3.61 Million USD | -4554.183% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -22036.495% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -638113.173% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 90.32% |
| CorMedix Inc. | 517.01 Thousand USD | -32397.442% |
| BioLineRx Ltd. | 6.62 Million USD | -2434.943% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -356.094% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -134.198% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1004.569% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -19845.18% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -65788.627% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -289.377% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -40813.651% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -12172.9% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -25237.996% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 5.646% |
| Biomea Fusion, Inc. | 7.83 Million USD | -2045.798% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 40.884% |
| Mereo BioPharma Group plc | 5.3 Million USD | -3070.113% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -7714.698% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -28474.15% |
| Absci Corporation | 4.66 Million USD | -3505.494% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -1358.219% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -640.322% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1579.32% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -1360.374% |
| Allakos Inc. | 38.21 Million USD | -339.66% |
| Imunon, Inc. | 1.13 Million USD | -14647.392% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1847.109% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -19997.608% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -1680060.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -90.18% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -3467.976% |
| XOMA Corporation | 118.51 Million USD | -41.764% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1568.646% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -353.13% |
| aTyr Pharma, Inc. | 13.76 Million USD | -1120.426% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -2027.054% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -573.033% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -731.557% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -1120006.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -60296.132% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1062.35% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 88.793% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -123284.224% |
| UroGen Pharma Ltd. | 98.55 Million USD | -70.486% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -12.676% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -781.187% |
| Entera Bio Ltd. | 256 Thousand USD | -65531.25% |
| GH Research PLC | 631 Thousand USD | -26526.941% |
| Lisata Therapeutics, Inc. | 137.00 USD | -122639316.058% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -26070.717% |
| Xencor, Inc. | 14.64 Million USD | -1047.494% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -111723.549% |
| Replimune Group, Inc. | 71.99 Million USD | -133.388% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -111910.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -2298.173% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -123284.224% |
| Portage Biotech Inc. | 7000.00 USD | -2400128.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -25237.996% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -11657.593% |
| OncoCyte Corporation | 2.2 Million USD | -7523.23% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -251026.224% |
| Purple Biotech Ltd. | 163 Thousand USD | -102977.301% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -6527.85% |
| scPharmaceuticals Inc. | 38.81 Million USD | -332.908% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -565.568% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -230058.904% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -8967.242% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -537.68% |
| Curis, Inc. | 1.48 Million USD | -11183.815% |
| Daré Bioscience, Inc. | 3.91 Million USD | -4193.048% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -23980.893% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -2800166.667% |
| BeiGene, Ltd. | 197.61 Million USD | 14.979% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -18332.913% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -108.521% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -223.799% |
| bluebird bio, Inc. | 224.41 Million USD | 25.133% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 71.671% |
| DBV Technologies S.A. | 4.52 Million USD | -3612.24% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -12438.507% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -1624.656% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -4360.207% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 55.464% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -291.856% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -9685.44% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -18005.172% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -861.905% |
| MacroGenics, Inc. | 30.19 Million USD | -456.418% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -849.082% |
| Prime Medicine, Inc. | 4.35 Million USD | -3756.231% |
| Aditxt, Inc. | 1.04 Million USD | -16028.339% |
| Adagene Inc. | 13.54 Million USD | -1140.883% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1123.091% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 67.609% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -882.952% |
| SciSparc Ltd. | 24 Thousand USD | -699966.667% |
| Vericel Corporation | 81.85 Million USD | -105.258% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -104.856% |
| Generation Bio Co. | 89.77 Million USD | -87.154% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -657.341% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 16.741% |
| Invivyd, Inc. | 722 Thousand USD | -23170.914% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -246.41% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -5746531.871% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -4292.575% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -730404.348% |
| 2seventy bio, Inc. | 244.01 Million USD | 31.145% |
| ADMA Biologics, Inc. | 130.59 Million USD | -28.655% |
| Clene Inc. | 7.15 Million USD | -2249.217% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -4876.395% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 32.147% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -15160.309% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -63817.22% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 12.773% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -491.543% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1643.085% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -50.454% |
| Evaxion Biotech A/S | 8.48 Million USD | -1879.279% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -124.246% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -159.625% |
| Trevena, Inc. | 35.23 Million USD | -376.871% |
| Surrozen, Inc. | 882 Thousand USD | -18949.433% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -2602.96% |
| Cingulate Inc. | 135.09 Thousand USD | -124265.095% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -613.777% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -251.498% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -93242.222% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -562.028% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -863.56% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -17850.427% |
| Statera Biopharma, Inc. | 11.43 Million USD | -1369.81% |
| ImmunityBio, Inc. | 836.95 Million USD | 79.925% |
| Korro Bio, Inc. | 31.21 Million USD | -438.237% |
| Kineta, Inc. | 150 Thousand USD | -111910.667% |
| BioVie Inc. | 349.89 Thousand USD | -47919.114% |
| Codexis, Inc. | 12.24 Million USD | -1272.343% |
| Celularity Inc. | 26.17 Million USD | -541.846% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -253.309% |
| Celcuity Inc. | 37.03 Million USD | -353.663% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -95176.872% |
| Cibus, Inc. | 17.67 Million USD | -850.639% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -4872.359% |
| Kodiak Sciences Inc. | 100 Million USD | -68.016% |
| Annexon, Inc. | 29.19 Million USD | -475.594% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -159.978% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -14874.688% |
| Avalo Therapeutics, Inc. | 2 Million USD | -8300.8% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 88.002% |
| Eyenovia, Inc. | 8.95 Million USD | -1775.758% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -155.892% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1963.572% |
| Arcellx, Inc. | 50.84 Million USD | -230.473% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -11423.731% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -691.11% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -15825.687% |
| Moolec Science SA | 99.04 Thousand USD | -169534.311% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -508.291% |
| Geron Corporation | 35.05 Million USD | -379.347% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -28329.103% |
| Royalty Pharma plc | 6.13 Billion USD | 97.261% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -10132.4% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -529217.623% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -625.834% |
| Humacyte, Inc. | 38.6 Million USD | -335.275% |
| Structure Therapeutics Inc. | 4.01 Million USD | -4086.793% |
| 89bio, Inc. | 24.79 Million USD | -577.62% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -1251.263% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -8904.073% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -16180.62% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -68.847% |
| Notable Labs, Ltd. | 1.52 Million USD | -10910.223% |
| Liquidia Corporation | 2.36 Million USD | -7007.276% |
| Mustang Bio, Inc. | 1.97 Million USD | -8394.237% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1123.091% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -2316.453% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -52901.893% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -236.861% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1649.438% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -256456.063% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -123441.176% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -2582.248% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -129143.077% |
| PepGen Inc. | 17.1 Million USD | -882.55% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -35346.414% |
| United Therapeutics Corporation | 300 Million USD | 43.995% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -601.792% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -3936.079% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -28968.512% |
| XOMA Corporation | 118.51 Million USD | -41.764% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -453997.297% |
| Bionomics Limited | 117.62 Million USD | -42.837% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -17908.146% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2894.938% |
| uniQure N.V. | 130.06 Million USD | -29.178% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -186.766% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -24392.128% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -3774.014% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -12031.119% |
| Altimmune, Inc. | 175 Thousand USD | -95909.143% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 56.681% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -2894.938% |
| Compugen Ltd. | 719 Thousand USD | -23268.011% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -3216.542% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -98.706% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1592.004% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -2533.892% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -83.805% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1592.004% |
| Instil Bio, Inc. | 81.42 Million USD | -106.339% |
| argenx SE | 15.35 Million USD | -994.282% |
| Immunome, Inc. | 1.34 Million USD | -12438.507% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -31246.269% |
| Verona Pharma plc | 48.37 Million USD | -247.327% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -1723.09% |
| Shattuck Labs, Inc. | 3.4 Million USD | -4832.942% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -197565.882% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -99909.524% |
| Moolec Science SA | 99.04 Thousand USD | -169534.311% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -1422.979% |
| AnaptysBio, Inc. | 16.03 Million USD | -947.677% |
| Design Therapeutics, Inc. | 2.33 Million USD | -7098.629% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -620549.403% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -2700.267% |
| Achilles Therapeutics plc | 1.07 Million USD | -15514.87% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -1723.09% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -842676.886% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -903.534% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -210377.789% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -2251823.335% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -1292330.769% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 50.942% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -586.228% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -6620.667% |
| Palisade Bio, Inc. | 90 Thousand USD | -186584.444% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -86506.186% |
| Beam Therapeutics Inc. | 159.91 Million USD | -5.068% |
| Neurogene Inc. | 13.37 Million USD | -1156.382% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 45.168% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -539.744% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -280759.884% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -16701.6% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -314.772% |
| Athira Pharma, Inc. | 1.21 Million USD | -13705.752% |
| Vaccinex, Inc. | 26 Thousand USD | -646115.385% |
| HCW Biologics Inc. | 6.3 Million USD | -2565.094% |
| XOMA Corporation | 118.51 Million USD | -41.764% |
| Nektar Therapeutics | 112.62 Million USD | -49.182% |
| Arvinas, Inc. | 800 Thousand USD | -20902.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1062.35% |
| Merus N.V. | 10.48 Million USD | -1501.983% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -1028.76% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -1151.143% |
| Rezolute, Inc. | 1.66 Million USD | -10021.446% |
| Clene Inc. | 7.15 Million USD | -2249.217% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -228966.914% |
| BeyondSpring Inc. | 3.36 Million USD | -4894.53% |
| Synlogic, Inc. | 12.49 Million USD | -1245.096% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -414.503% |
| Krystal Biotech, Inc. | 6.62 Million USD | -2438.006% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 1.698% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -2702.135% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -354581.134% |
| MannKind Corporation | 252.15 Million USD | 33.367% |
| Ikena Oncology, Inc. | 7.18 Million USD | -2240.056% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -84330.151% |
| Gossamer Bio, Inc. | 197.4 Million USD | 14.888% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -32210.769% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 40.278% |
| Mural Oncology plc | 8.91 Million USD | -1785.49% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -284.16% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -11600.279% |
| Champions Oncology, Inc. | 6.09 Million USD | -2657.525% |
| REGENXBIO Inc. | 82.22 Million USD | -104.344% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -33911.129% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -3689.265% |
| Vaxart, Inc. | 2.62 Million USD | -6305.49% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -61754.501% |
| Cellectis S.A. | 36.24 Million USD | -363.608% |
| Longeveron Inc. | 1.44 Million USD | -11503.315% |
| Repare Therapeutics Inc. | 1.01 Million USD | -16535.248% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 85.164% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -275.295% |
| Revolution Medicines, Inc. | 80.57 Million USD | -108.521% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -5137.406% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -94824.294% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -136498.374% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 76.816% |
| Denali Therapeutics Inc. | 44.98 Million USD | -273.527% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -1243.671% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -124265.095% |
| Passage Bio, Inc. | 22.92 Million USD | -633.022% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -2682.182% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -25868.47% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -733.206% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -34188.98% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -41135.271% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -14042.761% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -35954.936% |
| OmniAb, Inc. | 22.07 Million USD | -661.114% |
| Anew Medical, Inc. | 1.54 Million USD | -10810.13% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -468.39% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1760.024% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -440.418% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4044.184% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -225.884% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -2538.857% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1089.157% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -24902.381% |
| Alumis Inc. Common Stock | 30.86 Million USD | -444.446% |
| Equillium, Inc. | 384 Thousand USD | -43654.167% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -2627.975% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -11.233% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -243.739% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -139561.851% |
| Dominari Holdings Inc. | 3.02 Million USD | -5448.745% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -849624.372% |
| vTv Therapeutics Inc. | 169 Thousand USD | -99317.751% |
| Bio-Techne Corporation | 319 Million USD | 47.33% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -194.827% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 5.908% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -990.517% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -1256.828% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -3395.236% |
| Nkarta, Inc. | 82.27 Million USD | -104.225% |
| BioCardia, Inc. | 982 Thousand USD | -17009.572% |
| Iterum Therapeutics plc | 18.95 Million USD | -786.347% |